Search clinical trials for: Lapatinib, Vinorelbine
Total 1860 results
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States
-
Central European Cooperative Oncology GroupTerminatedMetastatic Breast CancerHungary, Austria
-
National Taiwan University HospitalGlaxoSmithKlineCompletedMetastatic Breast CancerTaiwan
-
Liaoning Tumor Hospital & InstituteNot yet recruitingTriple-negative Breast Cancer
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Yongchang ZhangCompletedAdvanced Non Small Cell Lung CancerChina
-
Sun Yat-sen UniversityCompletedHER2 Positive Breast CancerChina
-
Sponsor GmbHGlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische StudienTerminatedMetastatic Breast Cancer | HER2 Positive | First or Second Line Therapy | Failure or Contraindication of Trastuzumab TherapyGermany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Australia, Hong Kong, Korea, Republic of, Thailand, Tunisia, United Kingdom
-
UNICANCERCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of California, DavisNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Boehringer IngelheimCompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Brazil, Colombia, Peru
-
Boehringer IngelheimCompletedBreast NeoplasmsHong Kong, Taiwan, United Kingdom, Russian Federation, India, Poland
-
Byondis B.V.CompletedMetastatic Breast CancerFrance, United States, United Kingdom, Belgium, Spain, Italy, Singapore, Denmark, Sweden, Canada, Netherlands
-
University of MagdeburgBoehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Boehringer IngelheimCompletedBreast NeoplasmsKorea, Republic of, Spain, Canada, Germany, Singapore, China, United Kingdom, Taiwan, Israel, United States, Australia, Slovenia, Italy, Brazil, India, Czechia, Netherlands, Ireland, Poland, Belarus, Belgium, Portugal, Russian Federation and more
-
Boehringer IngelheimCompletedBreast Neoplasms | Neoplasm MetastasisUnited States, Canada, Finland, France, Germany, Italy, Korea, Republic of, Spain
-
Henan Cancer HospitalRecruiting
-
Xiangya Hospital of Central South UniversitySuzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingGastrointestinal Stromal TumorsChina
-
Shandong UniversityThe Affiliated Hospital of Qingdao University; Qianfoshan Hospital; The Second...Recruiting
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University Anam Hospital and other collaboratorsUnknownMetastatic Breast CancerKorea, Republic of
-
University Hospital of CreteTerminated
-
Sun Yat-sen UniversityRecruitingBreast Cancer | Breast Diseases | HER2-positive Breast Cancer | Vinorelbine | PyrotinibChina
-
Novartis PharmaceuticalsCompletedCancerGermany, Greece, Italy, Poland, Spain, Bulgaria, France, Serbia, Mexico, Chile
-
GlaxoSmithKlineCompletedCancerUnited States
-
Fudan UniversityCompletedAdvanced Triple-Negative Breast CancerChina
-
Institut Paoli-CalmettesSuspended
-
QLT Inc.TerminatedStage IV Non-small Cell Lung Cancer | Stage IIIb Non-small Cell Lung Cancer
-
German Breast GroupTerminatedMetastatic Breast CancerGermany
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; iOMEDICO AGCompletedHer2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast CancerGermany
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); United States Department of DefenseCompleted
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
GlaxoSmithKlineCompletedColorectal CancerUnited States, Canada
-
GlaxoSmithKlineTerminatedNeoplasms, BreastItaly, United Kingdom
-
GlaxoSmithKlineWithdrawn
-
Georgetown UniversityGlaxoSmithKlineCompletedHead and Neck Cancer | Colorectal Cancer | Lung CancerUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung Cancer (NSCLC)Sweden, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Turkey, United Kingdom, Germany, Poland, Ukraine, Argentina, Austria, Hungary, Netherlands, Slovakia, Taiwan, Chil... and more
-
Southern Europe New Drug OrganizationPierre Fabre Laboratories; AgennixUnknown
-
University of Alabama at BirminghamGlaxoSmithKlineTerminatedOvarian CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Massachusetts General Hospital; Washington University School of Medicine; Gla... and other collaboratorsCompletedNeurofibromatosis 2 | Vestibular Schwannoma | Acoustic Neuroma | NF2 | Auditory TumorUnited States
-
Tragara Pharmaceuticals, Inc.Terminated
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Israel
-
Indiana UniversityGlaxoSmithKlineTerminatedDuctal Carcinoma in SituUnited States